Abstract
An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.
| Original language | English (US) |
|---|---|
| Article number | 00457 |
| Journal | Frontiers in Oncology |
| Volume | 9 |
| Issue number | MAY |
| DOIs | |
| State | Published - Jan 1 2019 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Oncology
- Cancer Research
Cite this
}
Consensus report from the Miami liver proton therapy conference. / Chuong, Michael D.; Kaiser, Adeel; Khan, Fazal; Parikh, Parag; Ben-Josef, Edgar; Crane, Christopher; Brunner, Thomas; Okumura, Toshiyuki; Schreuder, Niek; Bentzen, Søren M.; Gutierrez, Alonso; Romero, Alejandra Mendez; Yoon, Sang Min; Sharma, Navesh; Kim, Tae Hyun; Kishi, Kazushi; Moeslein, Fred; Hoffe, Sarah; Schefter, Tracey; Hanish, Steven; Scorsetti, Marta; Apisarnthanarax, Smith.
In: Frontiers in Oncology, Vol. 9, No. MAY, 00457, 01.01.2019.Research output: Contribution to journal › Review article
TY - JOUR
T1 - Consensus report from the Miami liver proton therapy conference
AU - Chuong, Michael D.
AU - Kaiser, Adeel
AU - Khan, Fazal
AU - Parikh, Parag
AU - Ben-Josef, Edgar
AU - Crane, Christopher
AU - Brunner, Thomas
AU - Okumura, Toshiyuki
AU - Schreuder, Niek
AU - Bentzen, Søren M.
AU - Gutierrez, Alonso
AU - Romero, Alejandra Mendez
AU - Yoon, Sang Min
AU - Sharma, Navesh
AU - Kim, Tae Hyun
AU - Kishi, Kazushi
AU - Moeslein, Fred
AU - Hoffe, Sarah
AU - Schefter, Tracey
AU - Hanish, Steven
AU - Scorsetti, Marta
AU - Apisarnthanarax, Smith
PY - 2019/1/1
Y1 - 2019/1/1
N2 - An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.
AB - An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.
UR - http://www.scopus.com/inward/record.url?scp=85067651618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067651618&partnerID=8YFLogxK
U2 - 10.3389/fonc.2019.00457
DO - 10.3389/fonc.2019.00457
M3 - Review article
C2 - 31214502
AN - SCOPUS:85067651618
VL - 9
JO - Frontiers in Oncology
JF - Frontiers in Oncology
SN - 2234-943X
IS - MAY
M1 - 00457
ER -